← FDA DRUG APPROVALS

FDA ANDA · ANDA207733

NYSTATIN CREAM

Sponsor: CROWN LABS INC

APPLICATION
ANDA207733
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-26
LATEST ACTION
2017-09-26
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

NYSTATINPrescription
NYSTATIN 100,000 UNITS/GM · CREAM · TOPICAL

Approval history

2017-09-26UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →